市場調查報告書

藥物研發人工智能 (AI)的全球市場規模 - 各零件,各技術,各適應症,各終端用戶,各地區預測:2020年∼2026年

Global Artificial Intelligence in Drug Discovery Market Size study, by Component, by Technology, by Application, by End-User and Regional Forecasts 2020-2026

出版商 Bizwit Research & Consulting LLP 商品編碼 935970
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
藥物研發人工智能 (AI)的全球市場規模 - 各零件,各技術,各適應症,各終端用戶,各地區預測:2020年∼2026年 Global Artificial Intelligence in Drug Discovery Market Size study, by Component, by Technology, by Application, by End-User and Regional Forecasts 2020-2026
出版日期: 2020年05月01日內容資訊: 英文
簡介

全球藥物研發人工智能 (AI) 市場在2019年估算達到約2億6,000萬美元,2019年∼2026年的預測期間內預計將以年複合成長率40.7%以上的速度成長。

本報告提供全球藥物研發人工智能 (AI) 市場相關調查分析,提供市場概要,市場規模·預測,各市場區隔的市場分析,各地區的市場分析,競爭情形等相關的系統性資訊。

目錄

第1章 摘要整理

第2章 全球藥物研發人工智能 (AI) 市場定義和範圍

第3章 全球藥物研發人工智能 (AI) 市場動態

  • 藥物研發人工智能 (AI) 市場影響分析

第4章 全球藥物研發人工智能 (AI) 市場:產業分析

  • 波特的五力分析
  • PEST分析
  • 投資採用模式
  • 分析師的建議與結論

第5章 全球藥物研發人工智能 (AI) 市場:各零件

  • 市場概述
  • 實際成果 - 潛在的分析
  • 估計·預測
  • 子區隔分析

第6章 全球藥物研發人工智能 (AI) 市場:各技術

  • 市場概述
  • 實際成果 - 潛在的分析
  • 估計·預測
  • 子區隔分析

第7章 全球藥物研發人工智能 (AI) 市場:各適應症

  • 市場概述
  • 實際成果 - 潛在的分析
  • 估計·預測
  • 子區隔分析

第8章 全球藥物研發人工智能 (AI) 市場:各終端用戶

  • 市場概述
  • 實際成果 - 潛在的分析
  • 估計·預測
  • 子區隔分析

第9章 全球藥物研發人工智能 (AI) 市場:各地區分析

  • 市場概述
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 其他地區

第10章 競爭資訊

  • 主要市場策略
  • 企業簡介
    • Microsoft Corporation
    • NVIDIA Corporation
    • IBM Corporation
    • Google Inc.
    • Atomwise, Inc.
    • Deep Genomics
    • Cloud Pharmaceuticals, Inc.
    • Insilico Medicine
    • Benevolentai
    • Exscientia

第11章 調查流程

目錄

Global Artificial Intelligence (AI) in Drug Discovery Market is valued approximately at USD 260 million in 2019 and is anticipated to grow with a healthy growth rate of more than 40.7% over the forecast period 2019-2026. Artificial intelligence for drug discovery is a technology that uses distinct algorithms which add value in decision-making processes for drug discovery. The implementation of AI reduces the gap of researches and development in the drug manufacturing process and also help in the targeted of manufacturing of the drugs. For this reason, the biopharmaceutical industries are increasingly adopting AI technology to optimize the drug manufacturing process. Further, rising investment & funding in drug discovery, along with the surging need to control drug discovery & development costs and reduce time are the few factors responsible for high CAGR of the market over the forecast period. For instance, as per India Brand Equity Foundation, 2018, the Indian Government is planning a $640 million fund for boosting the drug discovery and pharmaceutical infrastructure. The initiative 'Pharma Vision 2020' of Indian Government has a goal for making India a major hub for drug discovery. This, in turn, is expected to accelerate the demand of artificial intelligence (AI) in drug discovery across the world. However, lack of awareness and high cost & technical limitation of AI decision-making are some major forces expected to impede the growth of global Artificial Intelligence (AI) in Drug Discovery market over the forecast period of 2020-2026.

The regional analysis of global Artificial Intelligence (AI) in Drug Discovery Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the rising focus on R&D & substantial investment, along with the high awareness of the AI in drug discovery among key players located in the region. However, Asia-Pacific is anticipated to exhibit highest growth rate / CAGR over the forecast period, due to constant technological advancements in the pharmaceutical sector and increasing number of pharmaceutical manufacturers in developing countries such as China and India.

Major market player included in this report are:

Microsoft Corporation

NVIDIA Corporation

IBM Corporation

Google Inc.

Atomwise, Inc.

Deep Genomics

Cloud Pharmaceuticals, Inc.

Insilico Medicine

Benevolentai

Exscientia

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Component:

Software

Services

By Technology:

Machine Learning

Deep Learning

Others

By Application:

Immuno-Oncology

Neurodegenerative Diseases

Cardiovascular Diseases

Others

By End-User:

Pharmaceutical & Biotechnology Companies

Contract Research Organizations

Research Centers

Academic & Government Institutes

By Region:

North America

U.S.

Canada

Europe

UK

Germany

Asia Pacific

China

India

Japan

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2016, 2017, 2018

Base year - 2019

Forecast period - 2020 to 2026

Target Audience of the Global Artificial Intelligence (AI) in Drug Discovery Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

TABLE OF CONTENTS

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2018-2026 (USD Million)
    • 1.2.1. Artificial Intelligence (AI) in Drug Discovery Market, by Component, 2018-2026 (USD Million)
    • 1.2.2. Artificial Intelligence (AI) in Drug Discovery Market, by Technology, 2018-2026 (USD Million)
    • 1.2.3. Artificial Intelligence (AI) in Drug Discovery Market, by Application, 2018-2026 (USD Million)
    • 1.2.4. Artificial Intelligence (AI) in Drug Discovery Market, by End-User, 2018-2026 (USD Million)
    • 1.2.5. Artificial Intelligence (AI) in Drug Discovery Market, by Region, 2018-2026 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Artificial Intelligence (AI) in Drug Discovery Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Artificial Intelligence (AI) in Drug Discovery Market Dynamics

  • 3.1. Artificial Intelligence (AI) in Drug Discovery Market Impact Analysis (2018-2026)
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Global Artificial Intelligence (AI) in Drug Discovery Market Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2016-2026)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Artificial Intelligence (AI) in Drug Discovery Market, by Component

  • 5.1. Market Snapshot
  • 5.2. Global Artificial Intelligence (AI) in Drug Discovery Market by Component, Performance - Potential Analysis
  • 5.3. Global Artificial Intelligence (AI) in Drug Discovery Market Estimates & Forecasts by Component 2016-2026 (USD Million)
  • 5.4. Artificial Intelligence (AI) in Drug Discovery Market, Sub Segment Analysis
    • 5.4.1. Software
    • 5.4.2. Services

Chapter 6. Global Artificial Intelligence (AI) in Drug Discovery Market, by Technology

  • 6.1. Market Snapshot
  • 6.2. Global Artificial Intelligence (AI) in Drug Discovery Market by Technology, Performance - Potential Analysis
  • 6.3. Global Artificial Intelligence (AI) in Drug Discovery Market Estimates & Forecasts by Technology 2016-2026 (USD Million)
  • 6.4. Artificial Intelligence (AI) in Drug Discovery Market, Sub Segment Analysis
    • 6.4.1. Machine Learning
    • 6.4.2. Deep Learning
    • 6.4.3. Others

Chapter 7. Global Artificial Intelligence (AI) in Drug Discovery Market, by Application

  • 7.1. Market Snapshot
  • 7.2. Global Artificial Intelligence (AI) in Drug Discovery Market by Application, Performance - Potential Analysis
  • 7.3. Global Artificial Intelligence (AI) in Drug Discovery Market Estimates & Forecasts by Application 2016-2026 (USD Million)
  • 7.4. Artificial Intelligence (AI) in Drug Discovery Market, Sub Segment Analysis
    • 7.4.1. Immuno-Oncology
    • 7.4.2. Neurodegenerative Diseases
    • 7.4.3. Cardiovascular Diseases
    • 7.4.4. Others

Chapter 8. Global Artificial Intelligence (AI) in Drug Discovery Market, by End-User

  • 8.1. Market Snapshot
  • 8.2. Global Artificial Intelligence (AI) in Drug Discovery Market by End-User, Performance - Potential Analysis
  • 8.3. Global Artificial Intelligence (AI) in Drug Discovery Market Estimates & Forecasts by End-User 2016-2026 (USD Million)
  • 8.4. Artificial Intelligence (AI) in Drug Discovery Market, Sub Segment Analysis
    • 8.4.1. Pharmaceutical & Biotechnology Companies
    • 8.4.2. Contract Research Organizations
    • 8.4.3. Research Centers
    • 8.4.4. Academic & Government Institutes

Chapter 9. Global Artificial Intelligence (AI) in Drug Discovery Market, Regional Analysis

  • 9.1. Artificial Intelligence (AI) in Drug Discovery Market, Regional Market Snapshot
  • 9.2. North America Artificial Intelligence (AI) in Drug Discovery Market
    • 9.2.1. U.S. Artificial Intelligence (AI) in Drug Discovery Market
      • 9.2.1.1. Component breakdown estimates & forecasts, 2016-2026
      • 9.2.1.2. Technology breakdown estimates & forecasts, 2016-2026
      • 9.2.1.3. Application breakdown estimates & forecasts, 2016-2026
      • 9.2.1.4. End-User breakdown estimates & forecasts, 2016-2026
    • 9.2.2. Canada Artificial Intelligence (AI) in Drug Discovery Market
  • 9.3. Europe Artificial Intelligence (AI) in Drug Discovery Market Snapshot
    • 9.3.1. U.K. Artificial Intelligence (AI) in Drug Discovery Market
    • 9.3.2. Germany Artificial Intelligence (AI) in Drug Discovery Market
    • 9.3.3. Rest of Europe Artificial Intelligence (AI) in Drug Discovery Market
  • 9.4. Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market Snapshot
    • 9.4.1. China Artificial Intelligence (AI) in Drug Discovery Market
    • 9.4.2. India Artificial Intelligence (AI) in Drug Discovery Market
    • 9.4.3. Japan Artificial Intelligence (AI) in Drug Discovery Market
    • 9.4.4. Rest of Asia Pacific Artificial Intelligence (AI) in Drug Discovery Market
  • 9.5. Latin America Artificial Intelligence (AI) in Drug Discovery Market Snapshot
    • 9.5.1. Brazil Artificial Intelligence (AI) in Drug Discovery Market
    • 9.5.2. Mexico Artificial Intelligence (AI) in Drug Discovery Market
  • 9.6. Rest of The World Artificial Intelligence (AI) in Drug Discovery Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Microsoft Corporation
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Component Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. NVIDIA Corporation
    • 10.2.3. IBM Corporation
    • 10.2.4. Google Inc.
    • 10.2.5. Atomwise, Inc.
    • 10.2.6. Deep Genomics
    • 10.2.7. Cloud Pharmaceuticals, Inc.
    • 10.2.8. Insilico Medicine
    • 10.2.9. Benevolentai
    • 10.2.10. Exscientia

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption

List of Tables

List of Tables

  • TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET
  • TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET
  • TABLE 3. GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET, REPORT SCOPE
  • TABLE 4. YEARS CONSIDERED FOR THE STUDY
  • TABLE 5. EXCHANGE RATES CONSIDERED
  • TABLE 6. GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD MILLION)
  • TABLE 7. GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY COMPONENT 2016-2026 (USD MILLION)
  • TABLE 8. GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY TECHNOLOGY 2016-2026 (USD MILLION)
  • TABLE 9. GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY APPLICATION 2016-2026 (USD MILLION)
  • TABLE 10. GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY END-USER 2016-2026 (USD MILLION)
  • TABLE 11. GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 12. GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 13. GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 14. GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 15. GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 16. GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 17. GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 18. GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 19. GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 20. GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 21. U.S. ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 22. U.S. ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 23. U.S. ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 24. CANADA ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 25. CANADA ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 26. CANADA ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 27. UK ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 28. UK ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 29. UK ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 30. GERMANY ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 31. GERMANY ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 32. GERMANY ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 33. ROE ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 34. ROE ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 35. ROE ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 36. CHINA ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 37. CHINA ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 38. CHINA ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 39. INDIA ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 40. INDIA ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 41. INDIA ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 42. JAPAN ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 43. JAPAN ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 44. JAPAN ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 45. ROAPAC ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 46. ROAPAC ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 47. ROAPAC ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 48. BRAZIL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 49. BRAZIL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 50. BRAZIL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 51. MEXICO ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 52. MEXICO ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 53. MEXICO ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 54. ROLA ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 55. ROLA ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 56. ROLA ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 57. ROW ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 58. ROW ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 59. ROW ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

List of Figures

List of Figures

  • FIG 1. GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET, RESEARCH METHODOLOGY
  • FIG 2. GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET, MARKET ESTIMATION TECHNIQUES
  • FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
  • FIG 4. GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET, KEY TRENDS 2019
  • FIG 5. GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET, GROWTH PROSPECTS 2020-2026
  • FIG 6. GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET, PORTERS 5 FORCE MODEL
  • FIG 7. GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET, PEST ANALYSIS
  • FIG 8. GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET, VALUE CHAIN ANALYSIS
  • FIG 9. GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 10. GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 11. GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 12. GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 13. GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 14. GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET, REGIONAL SNAPSHOT 2016 & 2026
  • FIG 15. NORTH AMERICA ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET 2016 & 2026 (USD MILLION)
  • FIG 16. EUROPE ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET 2016 & 2026 (USD MILLION)
  • FIG 17. ASIA PACIFIC ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET 2016 & 2026 (USD MILLION)
  • FIG 18. LATIN AMERICA ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET 2016 & 2026 (USD MILLION)
  • FIG 19. GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET, COMPANY MARKET SHARE ANALYSIS (2019)